Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hajage

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Neuro-Oncology Advances|July 10, 2020
A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA)Florence Laigle-Donadey, François Ducray, Matthieu Boone, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 5, 2020
Impact of Point-of-care Testing on Length of Stay of Patients in the Emergency Department: A Cluster-randomized Controlled StudyPierre Hausfater, David Hajage, Julie Bulsei, et al.
Annals of Intensive Care|May 14, 2021
Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICUMartin Dres, David Hajage, Said Lebbah, et al.
Intensive Care Medicine|November 16, 2018
Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched studyPichoy Danial, David Hajage, Lee S Nguyen, et al.
Breast (Edinburgh, Scotland)|April 26, 2012
High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patientsAnne Vincent-Salomon, David Hajage, Alexandre Rouquette, et al.
Breast Cancer Research : BCR|February 15, 2012
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational studyFrançois-Clément Bidard, David Hajage, Thomas Bachelot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patientsAntonio Giordano, Brian L Egleston, David Hajage, et al.
BMC Cardiovascular Disorders|June 19, 2017
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational studyJulian P Halcox, José R Banegas, Carine Roy, et al.
BJU International|May 16, 2012
Severe post-renal acute kidney injury, post-obstructive diuresis and renal recoveryAïcha Hamdi, David Hajage, Emmanuel Van Glabeke, et al.
Annals of Intensive Care|May 19, 2016
Can we improve transthoracic echocardiography training in non-cardiologist residents? Experience of two training programs in the intensive care unitVincent Labbé, Stéphane Ederhy, Blandine Pasquet, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Neuro-Oncology Advances|July 10, 2020
A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA)Florence Laigle-Donadey, François Ducray, Matthieu Boone, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 5, 2020
Impact of Point-of-care Testing on Length of Stay of Patients in the Emergency Department: A Cluster-randomized Controlled StudyPierre Hausfater, David Hajage, Julie Bulsei, et al.
Annals of Intensive Care|May 14, 2021
Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICUMartin Dres, David Hajage, Said Lebbah, et al.
Intensive Care Medicine|November 16, 2018
Percutaneous versus surgical femoro-femoral veno-arterial ECMO: a propensity score matched studyPichoy Danial, David Hajage, Lee S Nguyen, et al.
Breast (Edinburgh, Scotland)|April 26, 2012
High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patientsAnne Vincent-Salomon, David Hajage, Alexandre Rouquette, et al.
Breast Cancer Research : BCR|February 15, 2012
Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational studyFrançois-Clément Bidard, David Hajage, Thomas Bachelot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2013
Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patientsAntonio Giordano, Brian L Egleston, David Hajage, et al.
BMC Cardiovascular Disorders|June 19, 2017
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational studyJulian P Halcox, José R Banegas, Carine Roy, et al.
BJU International|May 16, 2012
Severe post-renal acute kidney injury, post-obstructive diuresis and renal recoveryAïcha Hamdi, David Hajage, Emmanuel Van Glabeke, et al.
Annals of Intensive Care|May 19, 2016
Can we improve transthoracic echocardiography training in non-cardiologist residents? Experience of two training programs in the intensive care unitVincent Labbé, Stéphane Ederhy, Blandine Pasquet, et al.
Pageof 14